Spotlight
Clinical
CME
Partners
Glaucoma 360: Lowering IOP using the MIMS solution
ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.
ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma called MIMS — Minimally Invasive Micro Sclerostomy — solution, designed to create a single-patient-use sterile tool and a multi-use external machine, during the 2020 Glaucoma 360 meeting in San Francisco, California.
Articles in this issue
Assessing the angle: Getting back to basics
OCTA: The jury is still out
Funding new technologies for glaucoma treatment
Glaucoma drug delivery devices enter new frontier
Glaucoma devices: Now and in the future
Glaucoma 360: Lowering IOP using the MIMS solution
Beating burnout with camaraderie
Status of glaucoma: diagnostics and treatments in flux
Next frontier in glaucoma: Beyond IOP-lowering treatments
Normal tension glaucoma: testing diagnostic skills
Diagnostics: Innovative ways of looking at glaucoma
Glaucoma medications: Getting down to the basics
Glaucoma devices provide impressive IOP-lowering results
Glaucoma 360: Decision-making in surgical glaucoma
Glaucoma treatment alternatives: Thinking outside the box
Related Videos
Related Content
